FDA inspection
Gland Pharma Limited: FDA inspection ending Jul 14, 2023
FDA inspection 1210381 · Voluntary Action Indicated (VAI) · Hyderabad
Key facts
| Inspection ID | 1210381 |
|---|---|
| Firm | Gland Pharma Limited |
| FEI number | 3002647489 |
| Address | Survey 143 - 148, 150 - 151 D P Pally; Gandimaisammam Cross Road |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Jul 14, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data